Anebulo Pharmaceuticals Inc (ANEB)

Anebulo Pharmaceuticals Inc (ANEB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $12.8M; returns 1 day +0.0%.

Anebulo Pharmaceuticals Inc. is a clinical-stage biotechnology company primarily focused on developing novel treatments for acute cannabinoid intoxication (ACI) and other cannabis-induced toxicities, as well as substance addiction. The company's lead product candidate is ANEB-001 (selonabant), a potent, small molecule cannabinoid receptor type-1 (CB1) antagonist.

Groups ANEB belongs to

• Clinical Stage Biotech
• Biotechnology
• Clinical Stage
• Pharmaceuticals
• Healthcare
• Unmet Medical Needs
• CNS Disorders
• Life Sciences

ANEB financial model: income statement, cash flow and balance sheet